COVID-19 Aptamers

About Base Pair Biotechnologies

Base Pair Biotechnologies is a private, US-based biotech firm focused on aptamer discovery and development. The company employs a consultative, project-based business model, offering services from initial target consultation through functional aptamer testing and optimization. Its core technology includes a multiplexed SELEX platform and proprietary bioinformatics for selecting aptamers against challenging targets, including small molecules and toxins. While primarily a service provider, the company is actively exploring the therapeutic and diagnostic potential of aptamers, indicating a platform with potential for internal asset development.